Bios Fund III NT, Director: Actuate Therapeutics ACTU Buy · Filed 24/08/14

Trade details

Type: Insider buy
Amount: $1,000,000
Shares · price: 125,000 sh · $8.00 a share
Held after: 125,000 sh
Stock: Actuate Therapeutics ACTU
Person: Bios Fund III NTDirector
Trade date: 24/08/14
Filed: 24/08/14
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 23 insiders

Actuate Therapeutics trades, last 26 weeks

What else happened in Actuate Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/15~24/09/13

Bios Fund III NT's recent trades

Bios Fund III NTDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund III NTDirector
SellActuate Therapeutics
Sell
Actuate Therapeutics
ACTU
$138.9K
17,361 sh
$138.9K
Filed 24/08/20
Traded 24/08/14
Bios Fund III NTDirector
SellActuate Therapeutics
Sell
Actuate Therapeutics
ACTU
$42.5K
5,314 sh
$42.5K
Filed 24/08/20
Traded 24/08/14
Bios Fund III NTDirector
SellActuate Therapeutics
Sell
Actuate Therapeutics
ACTU
$18.6K
2,324 sh
$18.6K
Filed 24/08/20
Traded 24/08/14
Bios Fund III NTDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$3M
375,000 sh
$3M
Filed 24/08/14
Traded 24/08/14

Bios Fund III NT, Director — bought $1M of Actuate Therapeutics ACTU · 125,000 sh @ $8.00 | Whalegun